Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Replication competent helper functions for recombinant AAV vector generation.

L Cao1, M During, W Xiao

  • 1CNS Gene Therapy Center, Department of Neurosurgery, Thomas Jefferson University, Philadelphia, PA, USA.

Gene Therapy
|September 7, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Search for Lepton-Flavor-Violating Decay Modes B^{0}→K_{S}^{0}τ^{±}ℓ^{∓} with Hadronic B Tagging at Belle and Belle II.

Physical review letters·2025
Same author

[Intraoperative direct sonication for the diagnostic efficacy of periprosthetic joint infection].

Zhonghua wai ke za zhi [Chinese journal of surgery]·2025
Same author

Detection and measurement of urinary stones on virtual monoenergetic images derived from rapid tube voltage switching dual-energy CT.

Radiography (London, England : 1995)·2025
Same author

[Analysis of related factors for unexpected positive intraoperative cultures in aseptic hip revision surgery].

Zhonghua wai ke za zhi [Chinese journal of surgery]·2025
Same author

Measurement of CP Asymmetries in B^{0}→K_{S}^{0}π^{0}γ Decays at Belle II.

Physical review letters·2025
Same author

[Branched and fenestrated endovascular aortic repair in complex aortic diseases: innovative progress and clinical application].

Zhonghua wai ke za zhi [Chinese journal of surgery]·2024
Same journal

Improving the precision of AAV lung gene therapy for SP-B deficiency using computationally derived lung-specific promoters.

Gene therapy·2026
Same journal

Recent advancements in improving cross-species applicability of bioengineered AAV capsids.

Gene therapy·2026
Same journal

Assessment of F/HN-pseudotyped lentiviral vector following intravenous delivery to mice.

Gene therapy·2026
Same journal

Applications of genome editing technologies in the treatment of human diseases.

Gene therapy·2026
Same journal

High resolution ES-DMA quantifies AAV capsid DNA content by electrical mobility to mass correlation.

Gene therapy·2026
Same journal

AAV8-mediated mouse/human PROC expression rescues thrombophilia in hereditary protein C-deficient mice.

Gene therapy·2026
See all related articles

Researchers developed a novel Adeno-associated virus (AAV) helper function that enhances gene therapy vector production. This improved AAV helper function increases efficiency and quality for clinical applications.

Area of Science:

  • Molecular Biology
  • Gene Therapy
  • Virology

Background:

  • Adeno-associated virus (AAV) is a key vector for gene therapy, but current production methods are inefficient.
  • Existing AAV helper functions lack essential terminal repeats, limiting vector yield and quality.
  • Improvements are needed to meet the demand for economical, high-titer, high-quality recombinant AAV (rAAV) vectors for clinical use.

Purpose of the Study:

  • To design and validate a novel, highly efficient rAAV helper function.
  • To restore the cis-regulating function of AAV terminal repeats in the helper construct.
  • To improve the overall yield and quality of rAAV vectors for gene therapy applications.

Main Methods:

  • Designed a novel rAAV helper function incorporating AAV terminal repeats.

Related Experiment Videos

  • Introduced heterologous introns into the helper genome to control replication-competent AAV (rcAAV) contamination.
  • Utilized a mutant AAV terminal repeat defective in packaging to further prevent rcAAV formation.
  • Compared the performance of the new helper function in AAV-producing cell lines against existing systems.

    • Main Results:

    • The novel helper function replicates along with the vector plasmid, mimicking wild-type AAV growth.
    • Restoration of terminal repeat function enhanced AAV production efficiency.
    • The strategy effectively controlled contamination by replication-competent AAV particles.
    • The new helper function demonstrated superior performance in AAV-producing cell lines compared to non-replicating systems.

    Conclusions:

    • The developed AAV helper function significantly improves the efficiency and quality of rAAV vector production.
    • This novel strategy offers a promising solution for meeting the clinical demand for gene therapy vectors.
    • The enhanced helper function provides better control over rcAAV contamination, ensuring vector safety.